Zhejiang Xin Pharmaceutical

Zhejiang Jingxin Pharmaceutical is a China-based listed pharmaceutical company that integrates research and development, manufacturing, and commercialization of finished drugs, active pharmaceutical ingredients, intermediates, traditional Chinese medicines, biologic preparations, and certain medical devices. The company was founded in 1990 and is headquartered in Zhejiang, with dual headquarters in Xinchang and Hangzhou. Its commercial focus is concentrated in neuropsychiatric, cardiovascular and cerebrovascular, and digestive disease markets, while its broader portfolio also includes anti-infective, antidiabetic, and anti-inflammatory products. Jingxin operates as a diversified specialty and generic drug manufacturer rather than a venture-stage biotech, and it also maintains overseas sales and selected international R&D collaborations. Based on available public information, it appears to be an active commercial-stage healthcare company rather than a clinical-stage platform biotech.